Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review

por Steurer, Johann, Haller, Cyrill, Häuselmann, HansJörg, Brunner, Florian, Bachmann, Lucas M.
Publicado 2011

Correction: Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review

por Steurer, Johann, Haller, Cyrill, Häuselmann, HansJörg, Brunner, Florian, Bachmann, Lucas M.
Publicado 2011

Expert consensus on relevant risk predictors for the occurrence of osteoporotic fractures in specific clinical subgroups – Delphi survey

por Bodmer, Nicolas S., Häuselmann, Hans Jörg, Frey, Diana, Aeberli, Daniel, Bachmann, Lucas M.
Publicado 2019

Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey

por Jehle-Kunz, Sigrid, Häuselmann, Hans-Jörg, Keschawarzi, Mitra, Lamy, Olivier, Luzuy, Franck, Marcoli, Natalie, Meier, Christian, Uebelhart, Brigitte, Wiedersheim, Peter
Publicado 2022

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

por Everts-Graber, Judith, Bonel, Harald, Lehmann, Daniel, Gahl, Brigitta, Häuselmann, HansJörg, Studer, Ueli, Ziswiler, Hans-Rudolf, Reichenbach, Stephan, Lehmann, Thomas
Publicado 2023

Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

por Everts-Graber, Judith, Bonel, Harald, Lehmann, Daniel, Gahl, Brigitta, Häuselmann, HansJörg, Studer, Ueli, Ziswiler, Hans-Rudolf, Reichenbach, Stephan, Lehmann, Thomas
Publicado 2023

Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study

por Everts‐Graber, Judith, Bonel, Harald, Lehmann, Daniel, Gahl, Brigitta, Häuselmann, HansJörg, Studer, Ueli, Ziswiler, Hans‐Rudolf, Reichenbach, Stephan, Lehmann, Thomas
Publicado 2022